MBX Biosciences Inc. Common Stock
MBX | NASDAQ
$61.31
+$0.37 (+0.61%)
Sep 22, 2026, 9:36 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 248K | n/a | n/a | n/a |
Gross Profit | -248K | n/a | n/a | n/a |
Operating Income | -98.06M | -68.19M | -35.31M | -25.16M |
Interest Income | 11.08M | 6.27M | 2.75M | 372K |
Pretax Income | -86.97M | -61.92M | -32.56M | -26.14M |
Net Income | -86.97M | -61.92M | -32.56M | -26.14M |
Selling & General & Admin | 18.9M | 10.78M | 6.78M | 3.76M |
Research & Development | 79.16M | 57.42M | 28.53M | 21.4M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 98.06M | 68.19M | 35.31M | 25.16M |
Interest Expense | n/a | n/a | n/a | 374K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 98.06M | 68.19M | 35.31M | 25.16M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 36.51M | 33.39M | 31.85M | 31.85M |
Shares Outstanding (Diluted) | 36.51M | 33.39M | 31.85M | 31.85M |
EPS (Basic) | -2.38 | -1.85 | -1.02 | -0.82 |
EPS (Diluted) | -2.38 | -1.85 | -1.02 | -0.82 |
EBITDA | -86.72M | -61.68M | -32.41M | -25.71M |
EBIT | -86.97M | -61.92M | -32.56M | -25.76M |
Depreciation & Amortization | 248K | 244K | 157K | 56K |
Add to Watchlist
Select watchlists to add or remove MBX